Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Battery Ventures IX, L.P.
 2. Date of Event Requiring Statement (Month/Day/Year)
04/04/2011		 3. Issuer Name and Ticker or Trading Symbol
CHAMPIONS ONCOLOGY, INC. [CSBR.OB]
(Last)
(First)
(Middle)
930 WINTER STREET, SUITE 2500		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

WALTHAM, MA 02451		 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 5,466,667
I
By Funds (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to purchase shares of Common Stock 04/04/2011 04/04/2016 Common Stock 820,000 (2) $ 0.9 I By Funds (3)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Battery Ventures IX, L.P.
930 WINTER STREET
SUITE 2500
WALTHAM, MA 02451		     X    
Battery Investment Partners IX, LLC
930 WINTER STREET
SUITE 2500
WALTHAM, MA 02451		     X    
Battery Partners IX, LLC
930 WINTER STREET
SUITE 2500
WALTHAM, MA 02451		     X    

Signatures

/s/ Christopher Schiavo By: Christopher Schiavo (acting as attorney-in-fact on behalf of Battery Ventures IX, L.P.) 04/14/2011
**Signature of Reporting Person Date
/s/ Christopher Schiavo By: Christopher Schiavo (acting as attorney-in-fact on behalf of Battery Investment Partners IX, LLC) 04/14/2011
**Signature of Reporting Person Date
/s/ Christopher Schiavo By: Christopher Schiavo (acting as attorney-in-fact on behalf of Battery Partners IX, LLC) 04/14/2011
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Consists of 5,412,547 shares of the Issuer's Common Stock held by Battery Ventures IX, L.P. ("BVIX") and 54,120 shares of the Issuer's Common Stock held by Battery Investment Partners IX, LLC ("BIPIX"). BVIX and BIPIX are under common control, as Battery Partners IX, LLC ("BPIX") is the sole general partner of BVIX and the sole manager of BIPIX. BVIX, BIPIX and BPIX expressly disclaim beneficial ownership over all shares held by BVIX, BIPIX and BPIX, except to the extent of their indirect pecuniary interest therein.
(2) The number of shares of common stock issuable upon the exercise of the warrant is subject to certain adjustments for dividends, combinations of stock, reorganizations or mergers or similar transactions pursuant to the terms of the warrant.
(3) Consists of a warrant to purchase 811,882 shares of the Issuer's Common Stock held by BVIX and a warrant to purchase 8,118 shares of the Issuer's Common Stock held by BIPIX. BVIX and BIPIX are under common control, as BPIX is the sole general partner of BVIX and the sole manager of BIPIX. BVIX, BIPIX and BPIX expressly disclaim beneficial ownership over all shares held by BVIX, BIPIX and BPIX, except to the extent of their indirect pecuniary interest therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.